France· FR:68438457
ADCETRIS 50 mg, poudre pour solution à diluer pour perfusion
A medicinal product, registered in France by TAKEDA PHARMA (DANEMARK).
Checked against Base de données publique des médicaments — BDPM (France) on
Informational only — not a medical device.
The record
At a glance
Base de données publique des médicaments — BDPM (France)- Manufacturer
- TAKEDA PHARMA (DANEMARK)
- Country
- France (FR)
- ATC code
- —
- Reimbursed
- No
- Source register
- Base de données publique des médicaments — BDPM (France)
- Last checked
- September 12, 2026
Packs & prices · 1
- cip1334009583971891 flacon(s) en verre
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
ADCETRIS in 15 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- NetherlandsAdcetris 50 mg, poeder voor concentraat voor oplossing voor infusieTakeda Pharma A/S
- FinlandADCETRIS2care4 ApS
- SwitzerlandAdcetris
- SpainADCETRIS 50 mg POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSIONTakeda Pharma A/S
- United KingdomAdcetris 50mg powder for concentrate for solution for infusion vialsTakeda UK Ltd
- IrelandADCETRIS 50 mg powder for concentrate for solution for infusionTakeda Pharma A/S
- IcelandADCETRISTakeda Pharma A/S
- Japanブレンツキシマブ ベドチン（遺伝子組換え）武田薬品工業
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Adcetris
- Liechtenstein · Adcetris
- Norway · Adcetris
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/2d4091cf-501a-4955-a284-c285a0791893 GET /v1/drugs/2d4091cf-501a-4955-a284-c285a0791893?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cis": "68438457",
"date_amm": "2012-10-25",
"type_amm": "Procédure centralisée",
"numero_ue": "EU/1/12/794",
"statut_amm": "Autorisation active",
"statut_bdm": null,
"forme_pharmaceutique": "poudre pour solution à diluer pour perfusion",
"voies_administration": "intraveineuse",
"etat_commercialisation": "Commercialisée",
"surveillance_renforcee": "Non"
}See everything about ADCETRIS.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.